- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-08-0002306

Caveat Pharma Private Limited
About Caveat Pharma Private Limited
Data last updated:
Caveat Pharma Private Limited is a private limited company based in Gurdaspur, Punjab, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 22 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24119PB2007PTC031229.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanchit Sood and Jaya Sood.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.690/7 Basant Avenue Mehar Chand Road Near Janjua Hospital, Gurdaspur, Punjab, India – 143521.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.16 Lakh, a growth of 83% compared to the previous year. For the same year it recorded a net profit of ₹41,926 (net margin 1.8%) and EBITDA of ₹62,419 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years and 8% over five years.
Caveat Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-08-0002306). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Caveat Pharma
Contact details
Caveat Pharma Private Limited's registered office is in Gurdaspur, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.690/7 Basant Avenue Mehar Chand Road Near Janjua Hospital, Gurdaspur, Punjab, India – 143521
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Caveat Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Caveat Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Caveat Pharma Private Limited, buy the company report.
Financials of Caveat Pharma Private Limited
FY 2024 filings availableCaveat Pharma Private Limited reported revenue of ₹23.16 Lakh (up 83% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 83% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹62,419 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41,926 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Caveat Pharma Private Limited, buy the company report.
Board of directors of Caveat Pharma Private Limited
Caveat Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanchit Sood | Director | 03 Jun 2021 | 5 Years 5 Months | Current |
| Jaya Sood | Director | 03 Jun 2021 | 5 Years 5 Months | Current |
Peer comparison
Caveat Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akshan Lifesciences Private Limited | ₹23.4 Lakh (FY 2025) | 9.0% | Dhanbad, Jharkhand, India | |||
| Derma Swift Health Care Private Limited | ₹23.39 Lakh (FY 2025) | 51.0% | New Delhi, Delhi, India | |||
| Raytwin Pharmaceutical Private Limited | ₹23.28 Lakh (FY 2025) | -8.0% | Bhiwandi, Maharashtra, India | |||
| Caveat Pharma Private Limitedthis company | ₹23.16 Lakh (FY 2024) | ₹41,926 | 1.8% | 83.0% | Gurdaspur, Punjab, India | |
| Joyce Healthcare Private Limited | ₹23.13 Lakh (FY 2017) | 62.0% | Thane, Maharashtra, India | |||
| Shard Lifesciences Private Limited | ₹23.06 Lakh (FY 2020) | -21.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Caveat Pharma Private Limited, buy the company report.
Auditor
Caveat Pharma Private Limited is audited by PP ARORA & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PP ARORA & ASSOCIATES | FY 2016 | 094179 |
Shareholding
The shareholding of Caveat Pharma Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Caveat Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Caveat Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Caveat Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Caveat Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Caveat Pharma Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Gagan Deep ceased to be Director on 20 Oct 2023.
Frequently asked questions
Caveat Pharma is an active private limited company based in Gurdaspur, Punjab, India. The company works in wholesale, within the trading industry. It was incorporated on 22 June 2007 (19+ years old) and is registered under CIN U24119PB2007PTC031229.
Caveat Pharma has 2 current directors:
- Sanchit Sood - Director
- Jaya Sood - Director
The latest financial statements of Caveat Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Caveat Pharma is U24119PB2007PTC031229. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caveat Pharma was incorporated on 22 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Caveat Pharma by revenue are Akshan Lifesciences Private Limited, Derma Swift Health Care Private Limited, Raytwin Pharmaceutical Private Limited, Joyce Healthcare Private Limited, Shard Lifesciences Private Limited, all in the Chemicals industry (Industrial Chemicals, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Gagan Deep ceased to be Director on 20 Oct 2023. Kiranjit Kaur ceased to be Director on 20 Oct 2023. Jaya Sood ceased to be Additional Director on 30 Nov 2021. Caveat Pharma has 7 board changes on record in total.
Yes, Caveat Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-08-0002306).
The registered office of Caveat Pharma is at H.No.6907 Basant Avenue Mehar Chand Road Near Janjua Hospital, Gurdaspur, Punjab, India – 143521.
Caveat Pharma operates in the trading industry, in the wholesale segment.
The compliance status of Caveat Pharma is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.

